ໜ້າທຳອິດRLF • SWX
add
RELIEF THERAPEUTICS Holding SA
ປິດກ່ອນໜ້າ
CHF 2,88
ຂອບເຂດລາຄາໃນມື້
CHF 2,79 - CHF 2,88
ຂອບເຂດລາຄາໃນປີ
CHF 1,65 - CHF 7,60
ມູນຄ່າຮຸ້ນຕາມລາຄາຕະຫຼາດ
40,56 ລ້ານ CHF
ປະລິມານສະເລ່ຍ
20,74 ພັນ
ອັດຕາ P/E
-
ເງິນປັນຜົນ
-
ຕະຫຼາດຂັ້ນຕົ້ນ
SWX
ຂ່າວຕະຫຼາດ
ກ່ຽວກັບ
Relief Therapeutics is a Swiss biopharmaceutical company based in Geneva. The company focuses on developing drugs for serious diseases with few or no existing treatment options. Its lead compound, RLF-100, is a synthetic form of a natural peptide that protects the lung. The company was incorporated as Relief Therapeutics Holdings AG and listed on the SIX Swiss Exchange in 2016. Wikipedia
ສ້າງຕັ້ງ
2013
ເວັບໄຊ
ພະນັກງານ
28